BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer.
Yan G, Luna A, Wang H, Bozorgui B, Li X, Sanchez M, Dereli Z, Kahraman N, Kara G, Chen X, Zheng C, McGrail D, Sahni N, Lu Y, Babur O, Cokol M, Lim B, Ozpolat B, Sander C, Mills GB, Korkut A.
Yan G, et al. Among authors: dereli z.
Cell Rep. 2022 Sep 13;40(11):111304. doi: 10.1016/j.celrep.2022.111304.
Cell Rep. 2022.
PMID: 36103824
Free PMC article.